Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
1.485
-0.095 (-6.01%)
Mar 31, 2025, 2:26 PM EDT - Market open
Lucid Diagnostics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Lucid Diagnostics stock have an average target of 3.75, with a low estimate of 2.00 and a high estimate of 7.00. The average target predicts an increase of 152.53% from the current stock price of 1.49.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Lucid Diagnostics stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $2 | Buy | Reiterates | $2 | +34.68% | Mar 26, 2025 |
Needham | Needham | Strong Buy Maintains $2.5 → $3 | Strong Buy | Maintains | $2.5 → $3 | +102.02% | Mar 24, 2025 |
Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $7.25 → $7 | Strong Buy | Maintains | $7.25 → $7 | +371.38% | Dec 9, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $3 → $2 | Buy | Maintains | $3 → $2 | +34.68% | Nov 15, 2024 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $3 | Strong Buy | Maintains | $3 | +102.02% | Nov 14, 2024 |
Financial Forecast
Revenue This Year
11.14M
from 4.35M
Increased by 156.40%
Revenue Next Year
34.14M
from 11.14M
Increased by 206.37%
EPS This Year
-0.70
from -1.05
EPS Next Year
-0.44
from -0.70
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 15.9M | 50.9M | 101.8M | ||
Avg | 11.1M | 34.1M | 66.4M | ||
Low | 6.9M | 11.0M | 32.6M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 264.8% | 356.6% | 198.0% | ||
Avg | 156.4% | 206.4% | 94.5% | ||
Low | 57.8% | -1.5% | -4.4% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -0.49 | -0.20 | -0.55 | ||
Avg | -0.70 | -0.44 | -0.53 | ||
Low | -0.82 | -0.65 | -0.51 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.